Загрузка...
Discontinuation of carbamazepine due to concerns of long‐term consequences of enzyme induction
OBJECTIVE: Treatment with carbamazepine (CBZ), a potent enzyme inducer, is known to affect the lipid profile, steroid, and vitamin D metabolism. Consequently, it has been postulated that patients on CBZ should be switched to noninducing antiepileptic drugs (AEDs). However, little is known about the...
Сохранить в:
| Опубликовано в: : | Epilepsia Open |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6119761/ https://ncbi.nlm.nih.gov/pubmed/30187004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/epi4.12227 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|